ENDRA Life Sciences, Inc. (NDRA) Francois Michelon, CEO

The Wall Street Resource

The pioneer of Thermo Acoustic Enhanced

UltraSound (TAEUS®), a

ground-breaking technology which characterizes tissue similar to an MRI, but at

1/50th the cost

and at the point of patient care. TAEUS® is designed to work in concert with the more than 700,000

ultrasound systems in use globally today. TAEUS® is initially focused on the measurement

of fat in the liver as a means to assess and monitor steatotic liver disease

(SLD) (formerly known as NAFLD-NASH), a chronic liver disease spectrum that

affects over two billion people globally, and for which there are no practical

diagnostic tools. Beyond the liver, ENDRA is exploring several other clinical

applications of TAEUS®, including

visualization of tissue temperature during energy-based surgical procedures.